188 related articles for article (PubMed ID: 32962636)
21. Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.
Liu Y; Nan F; Lu K; Wang Y; Liu Y; Wei S; Wu R; Wang Y
Cancer Biomark; 2017 Dec; 21(1):11-21. PubMed ID: 29060924
[TBL] [Abstract][Full Text] [Related]
22. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
23. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
[TBL] [Abstract][Full Text] [Related]
24. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Liu J; Liu F; Li X; Song X; Zhou L; Jie J
Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
[TBL] [Abstract][Full Text] [Related]
25. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
26. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
27. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
28. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
Peng Z; Xu B; Jin F
Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
[TBL] [Abstract][Full Text] [Related]
30. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
31. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
Pils D; Bachmayr-Heyda A; Auer K; Svoboda M; Auner V; Hager G; Obermayr E; Reiner A; Reinthaller A; Speiser P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Berger A; Cacsire Castillo-Tong D; Zeillinger R
Eur J Cancer; 2014 Jan; 50(1):99-110. PubMed ID: 24176298
[TBL] [Abstract][Full Text] [Related]
32. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
[TBL] [Abstract][Full Text] [Related]
33. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
Ma D; Zhang YY; Guo YL; Li ZJ; Geng L
Chin Med J (Engl); 2012 Dec; 125(23):4270-6. PubMed ID: 23217399
[TBL] [Abstract][Full Text] [Related]
34. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer.
Li G; Han L; Ren F; Zhang R; Qin G
J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442
[TBL] [Abstract][Full Text] [Related]
36. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
37. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
[TBL] [Abstract][Full Text] [Related]
38. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Guo S; Yang J; Wu M; Xiao G
Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
[TBL] [Abstract][Full Text] [Related]
39. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.
Bae J; Won M; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH; Suh DS
Int J Gynecol Cancer; 2012 May; 22(4):561-5. PubMed ID: 22543862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]